Issues
Today’s addition is a profitable small-cap MedTech company specializing in products to treat peripheral nerve injuries.
Management has a number of growth-oriented irons in the fire. And I think the company could be an attractive acquisition target.
While the sock has been relatively stable in this increasingly volatile market, we’ll still start with a half-sized position, just in case.
Management has a number of growth-oriented irons in the fire. And I think the company could be an attractive acquisition target.
While the sock has been relatively stable in this increasingly volatile market, we’ll still start with a half-sized position, just in case.
Updates
While the broad market has stabilized a little over the last couple of days, we are still very much in a risk-off environment. As we all know, the market hates uncertainty. And we’re getting plenty of it these days
On-again, off-again tariff threats are the big story this week with Trump’s latest comments reiterating March 4 as the date for Mexico and Canada tariffs and April 2 as the date for reciprocal tariffs (tariffs that match those levied by other countries on U.S. exports), and an additional 10% tariff on China as of that date.
On-again, off-again tariff threats are the big story this week with Trump’s latest comments reiterating March 4 as the date for Mexico and Canada tariffs and April 2 as the date for reciprocal tariffs (tariffs that match those levied by other countries on U.S. exports), and an additional 10% tariff on China as of that date.